Facilitating Access to Approved Medication

Spesolimab-Sbzo Injection
Spesolimab, is a monoclonal antibody medication used for the treatment of generalized pustular psoriasis (GPP). It is an interleukin-36 receptor (IL1RL2/IL1RAP) antibody. It was approved for medical use in the United States in September 2022.

Get Access To Spesolimab-Sbzo Injection

Ribociclib-tablets Available Price In India UK Saudi Arabia

spesolimab-sbzo injection

  • API: spesolimab-sbzo
  • Packaging: injection
  • Strength: Injection: 450 mg/7.5 mL (60 mg/mL) solution in a single-dose vial


Spesolimab is a prescription medicine used to treat the symptoms of Psoriasis (GPP). Spesolimab belongs to a class of drugs called Interleukin Inhibitors.
Spesolimab is an interleukin-36 receptor antagonist indicated for the treatment of generalized pustular psoriasis flares in adults. Active ingredient: spesolimab-sbzo Inactive ingredients: arginine hydrochloride, glacial acetic acid, polysorbate 20, sodium acetate, sucrose, and Water for Injection.

Note: (For Prescribing Information Approved Drugs, see)

  • The Food and Drug Administration (FDA), USA.
  • The European Medicines Agency (EMA).

    All Trademarks and Brands that appear on website belong to their respective owners does not lay and claim on them we only provide Information. We are NOT ONLINE store and We do not sell Narcotics and Sedatives. spesolimab-sbzo injection  is a pharmaceutical drug  To access this medicine, a prescription of your treating doctor is necessary.. Following Information meant for Wholesalers, Suppliers, Exporters, Doctors, Comparator Supplies, Hospitals, Generic, Brand, Corporate Sourcing, reseller, and Pharmacies.